Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

HIV vaccine development: current status and future challenges

¹Vaccine R&D Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Biotechnology Therapeutics

|January 1, 1991

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

Biologicals : journal of the International Association of Biological Standardization·2010

Same author

Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007.

Biologicals : journal of the International Association of Biological Standardization·2008

Same author

Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals.

AIDS research and human retroviruses·2000

Same author

Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex.

Proceedings of the National Academy of Sciences of the United States of America·1999

Same author

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity.

Vaccine·1997

Same author

International clinical trials of HIV vaccines: II. phase I trial of an HIV-1 synthetic peptide vaccine evaluating an accelerated immunization schedule in Yunnan, China.

Asian Pacific journal of allergy and immunology·1997